Celularity Inc current report, Q4 FY2024

Celularity Inc. Form 8-K Summary

Business Context and Reporting Period

This Form 8-K was filed by Celularity Inc. on November 8, 2024. The filing serves as a current report regarding the scheduling of the company's 2024 Annual Meeting of Stockholders and the associated deadlines for stockholder proposals.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.

Material Changes

No material financial changes are reported. The primary event is the establishment of the 2024 Annual Meeting date, which differs by more than 30 days from the anniversary of the 2023 Annual Meeting (held on June 14, 2023).

Guidance, Outlook, and Corporate Events

  • Annual Meeting Date: Thursday, December 19, 2024.
  • Record Date: Friday, November 8, 2024 (close of business).
  • Proposal Deadlines: Stockholder proposals for inclusion in proxy materials and nominations outside of Rule 14a-8 must be received by the close of business on November 18, 2024.
  • Submission Address: Corporate Secretary, 170 Park Avenue, Florham Park, NJ 07932.

Investor Verification Checklist

  • Verify the record date of November 8, 2024, to confirm eligibility to vote at the December 19, 2024, Annual Meeting.
  • Confirm the November 18, 2024, deadline for submitting stockholder proposals or director nominations.
  • Review Celularity's bylaws for specific formatting and content requirements for proposals to ensure compliance.